{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:13Z","timestamp":1791389113926,"version":"4.3.3"},"reference-count":34,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Patients with type 2 diabetes mellitus (T2DM) are at increased risk of non-alcoholic fatty liver disease (NAFLD) and might eventually progress to advanced fibrosis, cirrhosis and hepatocellular carcinoma (HCC). Recommendations on whether to screen for NAFLD in diabetic patients remains conflicted between major guidelines. Transient elastography using FibroScan with CAP (controlled attenuation parameter) can assess both liver steatosis and fibrosis simultaneously. This paper took a new look at the prevalence of NAFLD and the severity of fibrosis among T2DM patients in Vietnam. The study was conducted using a cross-sectional design in T2DM adults who attended Dai Phuoc Ho Chi Minh Polyclinic and Polyclinic of Pham Ngoc Thach University of Medicine. Liver steatosis and fibrosis was assessed by FibroScan. NAFLD was diagnosed if CAP &gt; 233 dB\/m (steatosis &gt; 5%). Data were analyzed using STATA 12 software program. We found that a total of 307 type 2 diabetic patients qualified for the study\u2019s criteria. The prevalence of NAFLD in T2DM patients based on FibroScan was 73.3%. Rates of mild, moderate and severe steatosis were 20.5%, 21.8% and 30.9%, respectively. The prevalence of significant fibrosis (\u2265 F2), advanced fibrosis (\u2265 F3) and cirrhosis (F4) was 13.0%, 5.9% and 3.6%, respectively. On multivariate analysis, aspartate aminotransferase (AST) (OR: 1.067; 95% CI: 1.017\u20131.119; p = 0.008) and platelet levels (OR: 0.985; 95% CI: 0.972\u20130.999; p = 0.034) were independent of risk factors of advanced fibrosis. Thus, our study supports screening for NAFLD and for evaluating the severity of liver fibrosis in T2DM patients.<\/jats:p>","DOI":"10.3390\/diagnostics10030159","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T09:27:41Z","timestamp":1584437261000},"page":"159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-7580","authenticated-orcid":false,"given":"Tran Thi Khanh","family":"Tuong","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8363-0918","authenticated-orcid":false,"given":"Dang Khoa","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Pham Ngoc Thach University of Medicine (PNTU), Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3433-1487","authenticated-orcid":false,"given":"Pham Quang Thien","family":"Phu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong Nguyen Diem","family":"Hong","sequence":"additional","affiliation":[{"name":"Dai Phuoc Polyclinic of Ho Chi Minh, Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien","family":"Chu Dinh","sequence":"additional","affiliation":[{"name":"Institute for Research and Development, Duy Tan University, 03 Quang Trung, Danang 550000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4596-2022","authenticated-orcid":false,"given":"Dinh Toi","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Human and Animal Physiology, Faculty of Biology, Hanoi National University of Education, Hanoi 100000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"key":"ref_1","unstructured":"LaBrecque, D., Abass, Z., Anania, F., and Ferenci, P. (2012). Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. World Gastroenterology Organisation Global Guidelines, WGO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4254\/wjh.v7.i13.1788","article-title":"Non-alcohol fatty liver disease in Asia: Prevention and planning","volume":"7","author":"Ashtari","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Vincent","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes","volume":"2","author":"Younossi","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"EASL, EASD, and EASO (2016). EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 59, 1121\u20131140.","DOI":"10.1007\/s00125-016-3902-y"},{"key":"ref_9","first-page":"13","article-title":"Classification and diagnosis of diabetes: Standards of medical care in diabetes 2018","volume":"Volume 41","author":"Riddle","year":"2018","journal-title":"Standards of Medical Care in Diabetes\u20142018"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: A prospective cohort study","volume":"65","author":"Kwok","year":"2015","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Karlas, T., Petroff, D., Garnov, N., and Bohm, S. (2014). Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and H-MR spectroscopy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091987"},{"key":"ref_13","unstructured":"World Health Organization (2000). The Asia-Pacific Perspective: Redefining Obesity and Its Treatment, WHO."},{"key":"ref_14","unstructured":"International Diabetes Federation (2006). The IDF Consensus Worldwide Definition of the Metabolic Syndrome, International Diabetes Federation."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"National, C.E.P.C.C. (2002). National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), International Medical publishing, Inc.","DOI":"10.1001\/jama.285.19.2486"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG practice guideline: Evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1751-2980.2010.00471.x","article-title":"Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis","volume":"12","author":"Adams","year":"2011","journal-title":"J. Dig. Dis."},{"key":"ref_19","first-page":"1396","article-title":"Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography","volume":"34","author":"Lai","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_20","first-page":"17654","article-title":"Controlled attenuation parameter for assessment of hepatic steatosis grades: A diagnostic meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.24726","article-title":"Ethnicity and nonalcoholic fatty liver disease","volume":"55","author":"Bambha","year":"2012","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the united states: A systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/jlts.2002.36740","article-title":"One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation","volume":"8","author":"Ryan","year":"2002","journal-title":"Liver Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1478-3231.2012.02824.x","article-title":"Controlled attenuation parameter (CAP): A new device for fast evaluation of liver fat?","volume":"32","author":"Paul","year":"2012","journal-title":"Liver Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-Pacifc working party on non-alcoholic fatty liver disease guidelines 2017-Part 1: Definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_26","first-page":"300","article-title":"Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population","volume":"26","author":"Wong","year":"2011","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.7314\/APJCP.2015.16.5.1789","article-title":"Non-alcoholic fatty liver disease (nafld) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes","volume":"16","author":"Sobhonslidsuk","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.dld.2011.12.005","article-title":"Screening for liver fibrosis by using FibroScan\u00ae and FibroTest in patients with diabetes","volume":"44","author":"Vergniol","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"ref_29","first-page":"00021","article-title":"Comparison of the transient elastography (fibroscan) results among diabetic and non-diabetic patients with non- alcoholic fatty liver disease","volume":"1","author":"Hajiani","year":"2014","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.14112","article-title":"Systematic review with meta-analysis: Risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients","volume":"46","author":"Sookoian","year":"2017","journal-title":"Aliment. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/clinchem\/24.11.1971","article-title":"Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues","volume":"24","author":"Rej","year":"1978","journal-title":"Clin. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2008.03674.x","article-title":"Review article: Blood platelet number and function in chronic liver disease and cirrhosis","volume":"27","author":"Witters","year":"2008","journal-title":"Aliment. Pharm. Ther."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/3\/159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:07:00Z","timestamp":1760173620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/3\/159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["diagnostics10030159"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10030159","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]}}}